Brussels, 2 December 2015
Members of the European Diagnostics Manufacturers Association (EDMA) and of the European Medical Technology Industry (Eucomed), both members of MedTech Europe, have approved a new Code of Ethical Business Practice at their General Assemblies held on 2 December in Brussels, in a continuous effort to set high ethical standards for the medical technology industry across Europe.
EDMA and Eucomed members have adopted a new common Code of Ethical Business Practice, in a move to put forward clearer and more stringent self-regulation. The code will replace the EDMA and Eucomed codes of business practice and will be known as the MedTech Europe Code of Business Practice.
In a continuous effort to reinforce their ethical standards, EDMA and Eucomed have decided to take the lead and push forward a high-standard and harmonised common Code of Ethical Business Practice for the European medical technology industry.
The decision to adopt a common Code was driven by the fact that both EDMA and Eucomed current codes were established in 2007 and 2008 respectively and had their own specificities, which created inconsistencies in the rules applied to the industry. With the deepening collaboration between EDMA and Eucomed, both organisations also saw the need to align their codes.
The new MedTech Europe Code regulates all aspects of the industry’s relationship with Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs), such as company-organised events, arrangements with consultants, research and financial support to medical education, amongst others. The Code also introduces a common independent enforcement mechanism.
The new MedTech Europe Code of Business Practice will become binding for EDMA and Eucomed corporate members by 1st January 2017. It will set the minimum standard by which industry members operate across Europe.
Rob Ten Hoedt, Chairman of MedTech Europe and Eucomed, said: “We are proud that the European medical technology industry has adopted one of the most modern and progressive codes of conduct, with strict, clear and transparent rules.”
Jürgen Schulze, Vice Chair of MedTech Europe and President of EDMA, added: “This is a landmark vote that reflects both how our industry is changing and how our partnership with healthcare professionals and healthcare organisations has evolved.”